Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use MARAVIROC TABLETS safely and effectively. See full prescribing information for MARAVIROC TABLETS. MARAVIROC tablets, for oral use Initial U.S. Approval: 2007
Medication labelWhy this: Advisory · dailymed-prescription
Maraviroc tablets are indicated in combination with other antiretroviral agents for the treatment of only CCR5-tropic human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients 2 years of age and older weighing at least 10 kg. Limitations of Use: • Maraviroc tablets are not recommended in patients with dual/mixed- or CXCR4-tropic HIV-1 [ see Microbiology ( 12.4) ].
- generic_name
- maraviroc
- product_names
- Maraviroc
- ndc
- 50090-8005, 31722-580, 50090-8005-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en